Pregnancy · Birth planning
VBAC Success Predictor
Predicted probability of successful vaginal birth after caesarean (VBAC) using the Grobman 2021 race-neutral MFMU model — the current clinical reference, replacing the original 2007 version that included race/ethnicity as predictors.
Last reviewed 25 May 2026
Vaginal birth after caesarean — probability
Units
How to use this calculator
Enter maternal age, height, current weight (used to compute BMI at delivery), and check the three clinical history toggles: any prior vaginal delivery, any prior successful VBAC, and whether the prior caesarean was for arrest of labour / failure to progress. The calculator returns the predicted probability of VBAC success and an interpretation band.
The model
Logistic regression on five predictors (Grobman 2021, race-neutral update):
logit(p) = 3.766
+ (−0.039 × age)
+ (−0.060 × BMI at delivery)
+ (0.888 × prior_vaginal_delivery)
+ (1.003 × prior_VBAC)
+ (−0.671 × prior_arrest_of_labor)
p = exp(logit) / (1 + exp(logit))Successful prior VBAC is the strongest positive predictor (+1.003 logit, equating to ~3× odds). Higher age and BMI reduce success modestly. A prior arrest-of-labour caesarean (recurring indication) reduces success by about 1.5× odds.
The 2021 race-neutral update — why it mattered
The original 2007 Grobman model included race and ethnicity as predictors. By design it lowered the predicted success for Black and Hispanic women. Subsequent analysis (Vyas 2019 NEJM; Sundaresan 2020) found this contributed to lower TOLAC offer rates in those groups. The 2021 update removed race and ethnicity, found equivalent overall calibration, and is the current ACOG-endorsed reference.
What the result means in practice
- ≥ 70 % — Favourable. Above-average success rate. TOLAC is a reasonable choice; uterine rupture risk in the same group remains ~0.5-1 %.
- 50-69 % — Moderate. Around-average. Risk-benefit balance depends on individual factors not in the model.
- < 50 % — Lower probability. Below-average. TOLAC remains an option, but the conversation should weigh higher chance of intrapartum caesarean against vaginal-birth benefits.
Uterine rupture — the safety story
TOLAC after one prior low-transverse caesarean carries a uterine rupture risk of ~0.5-1.0 % (ACOG PB 205, 2019). This is the biggest safety consideration. Rupture is an obstetric emergency requiring immediate caesarean; outcomes are best when recognised early and managed in a facility with 24/7 obstetric, anaesthetic, and surgical cover. TOLAC outside such facilities is generally not recommended.
Absolute contraindications to TOLAC
- Prior classical (vertical) uterine incision — rupture risk ~4-9 %.
- Prior uterine rupture.
- Contraindication to vaginal delivery (placenta praevia, transverse lie, etc.).
- Centres without 24/7 obstetric / anaesthetic / surgical cover (RCOG, ACOG joint position).
Limitations
- The model has 95 % calibration but individual prediction has wide intervals — a 70 % predicted rate can mean anywhere from 55-85 % at the individual level.
- Does not include: gestational age at delivery, fetal weight estimate, cervical Bishop score, induction vs spontaneous labour, inter-pregnancy interval, or local facility capability.
- The model is for women with ONE prior caesarean. After two or more, separate cohort studies apply (Mercer 2008; ACOG PB 205) — typically lower success and higher rupture risk.
- Multiple gestation, breech, and post-term TOLAC are outside the model’s training cohort.
Sources
- Grobman WA, Lai Y, Landon MB, et al. Development of a nomogram for prediction of vaginal birth after cesarean delivery. Obstet Gynecol 2007;109:806-12.
- Grobman WA, Sandoval G, Rice MM, et al. Prediction of vaginal birth after cesarean delivery in term gestations: a calculator without race and ethnicity. Am J Obstet Gynecol 2021;225:664.e1-7.
- ACOG. Practice Bulletin 205: Vaginal Birth After Cesarean Delivery. 2019 (reaffirmed 2022).
- NICE. Caesarean birth (NG192). 2021.
- Vyas DA, et al. Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms. N Engl J Med 2020;383:874-882.